Articles about IPO

Kestra Medical Technologies, maker of wearable cardiac devices, files for IPO

Kestra Medical Technologies, a Kirkland, Wash.-based company selling cardiac monitoring and therapeutic devices, filed for an initial public offering on… Read More

Will any Seattle startups go public this year? Analysts see better climate for tech IPOs

Seattle’s tech industry is in an IPO drought. Not a single tech company from the region went public via traditional… Read More

Industrial headset maker RealWear to go public via SPAC with Seattle investment bank

RealWear, a Vancouver, Wash.-based company that sells industrial hands-free wearable “assisted reality” headsets, is going public via a SPAC deal… Read More

Exit comeback: After big slowdown in IPO and M&A activity, analysts optimistic for a rebound

After startup exit activity took a nose dive in 2022 amid inflation, rising interest rates, and other macroeconomic forces, some… Read More

Buyers wanted: Exit opportunities for venture-backed startups sharply decline amid downturn

It’s getting harder for an early-stage company to find a buyer. The exit value for U.S. venture capital-backed startups in… Read More

Amazon-backed electric vehicle maker Rivian races to huge stock market debut after IPO

Rivian, the electric vehicle maker with substantial backing from Amazon, is arriving with a roar in its public debut on… Read More

‘Fall in love with a problem’: Remitly CEO reflects on startup journey as remittance company goes public

It’s been a heck of a startup journey for Remitly. The latest chapter begins Thursday when the mobile remittance company… Read More

Remitly prices IPO at $43/share; Seattle fintech giant valued at nearly $7B

Remitly will be valued at nearly $7 billion when it goes public on Thursday. The Seattle company priced shares at… Read More

Remitly aims to raise up to $332M at $6.5B valuation in IPO for Seattle fintech giant

Remitly set terms for its IPO on Tuesday. The fintech company expects to raise $284.6 million, or $332.6 million if… Read More

Money transfer startup Remitly reveals financial results in preparation for upcoming IPO

Seattle-based money remittance company Remitly disclosed key financial results on Monday afternoon in its Form S-1 registration statement, a key… Read More

Amazon-backed electric vehicle maker Rivian files to go public at reported $80B valuation

Rivian, the electric vehicle maker that has attracted huge funding from Amazon and others, announced Friday that it plans to… Read More

From hackathon to IPO: Pet sitting marketplace Rover is Seattle’s newest public company

It started as a simple pitch at a Seattle hackathon for a marketplace to facilitate matches between pet owners and… Read More

Icosavax stock skyrockets 200% on first day of trading for newly public Seattle biotech company

Icosavax is having quite the debut as Washington state’s newest public company. Shares of the Seattle-based biotech firm surged more… Read More

Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B

Shares of Absci surged more than 30% on Thursday as the Vancouver, Wash.-based biotech company made its debut as a… Read More

Eliem Therapeutics files for IPO as another Seattle-area biotech firm set to go public

Eliem Therapeutics, a clinical stage biotech company generating therapies for pain, depression and other nervous-system related conditions, has filed to… Read More

Vancouver, Wash. biotech company Absci files to go public

Absci, a Vancouver, Wash.-based company developing technologies to accelerate the process of drug discovery, announced today that it plans to… Read More

Remitly files initial IPO paperwork as Seattle fintech company prepares to go public

Remitly is going public. The mobile remittance company said Wednesday it confidentially submitted a draft registration statement with the SEC… Read More

Impel Neuropharma raises $80M in Washington state’s first IPO of 2021

The news: Seattle-based biotech company Impel NeuroPharma raised $80 million in its initial public offering and will begin trading on… Read More

Seattle biotech firm Impel NeuroPharma files for $75M IPO

Seattle-based biotech company Impel NeuroPharma is set to go public. The company, which develops drugs for central nervous system disorders… Read More

Qualtrics raises $1.55 billion in IPO, spinning out from SAP with plans to continue Seattle growth

A little more than two years ago, days before Qualtrics was set to go public, SAP swooped in with a… Read More

Silverback Therapeutics prices IPO at $21/share, will raise $241M in 4th Wash. state IPO of 2020

Silverback Therapeutics will raise $241.5 million as the Seattle biotech company goes public Friday. Silverback priced its IPO on Thursday… Read More

Seattle biotech firm Silverback Therapeutics sets terms for IPO, looks to raise up to $151M

Silverback Therapeutics plans to raise up to $151.8 million in its initial public offering, the Seattle-based company said Monday in… Read More

With deep roots in Seattle, real estate brokerage Compass reportedly eyes IPO

Heavily-funded real estate brokerage Compass hired Morgan Stanley and Goldman Sachs to lead an initial public offering next year, according… Read More

Shares of Laird Hamilton’s ‘superfood’ company nearly double on first day of trading

Laird Superfood stock doubled Wednesday before ending up at $40 per share on the first day of trading for the… Read More

Athira Pharma raises $204M in IPO, reaching ‘big milestone’ in fight against Alzheimer’s and other diseases

More than 5 million Americans have Alzheimer’s disease, and the number is projected to rise to nearly 14 million by… Read More

Athira Pharma prices IPO at $17/share, will raise $204M in third Washington state IPO of 2020

Athira Pharma will raise at least $204 million as the Seattle biotech startup becomes a public company on Friday. Athira… Read More

Snowflake stock soars in largest software IPO ever; Madrona among earlier venture investors

Snowflake came out with a bang in its public debut, raising $3.4 billion in the largest software IPO ever. The… Read More

Seattle biotech Athira Pharma sets terms for IPO, aims to raise up to $170M

Athira Pharma plans to price its stock at $15 to $17 per share and raise up to $170 million in… Read More

Bill Gates and Jeff Bezos-backed cancer detection company Grail, led by ex-Juno CEO, files for IPO

Cancer detection startup Grail today filed to go public as the Silicon Valley biotech aims to raise more funding for… Read More

Podcast

GeekWire Podcast: Breaking the IPO glass ceiling; Who succeeds Bezos?; TikTok’s ticking clock

Here’s what we’re talking about on the GeekWire Podcast this week. When Athira Pharma filed with the Nasdaq for a… Read More